Featured Research

from universities, journals, and other organizations

Protein provides link between calcium signaling in excitable and non-excitable cells

Date:
October 1, 2010
Source:
Temple University
Summary:
A calcium-sensing protein, STIM1, known to activate store-operated calcium channels has been found to also inhibit voltage-operated calcium channels.

A calcium-sensing protein, STIM1, known to activate store-operated calcium channels has been found to also inhibit voltage-operated calcium channels, according to researchers at Temple University.

The researchers published their findings in the Oct. 1 issue of Science.

Calcium, not just important for bones and teeth, is a universal signaling agent that is pivotal in controlling a wide range of cell functions including fast muscle and nerve responses and slower response such as cell division, cell growth, apoptosis or programmed cell death and even fertilization of eggs.

Calcium is stored in cells and rapidly released out and pumped back to control things like contraction of muscle or the triggering of immune cells said Donald Gill, Professor and Chair of Biochemistry in Temple's School of Medicine and the study's lead researcher.

He said that the STIM1 protein, which he helped discover about 5 years ago, was found to play a major role in sensing the low levels of calcium in cell stores and activating the highly selective Orai calcium channel to allow calcium to flow back into the cell.

"We thought it seemed crazy that the STIM1 protein goes through this incredible dance but the only thing it does is activate the Orai channel," he said. "It seemed difficult to believe it only had this one specific function."

About two years ago, Gill and his colleagues noticed that in addition to activating the Orai channel to allow calcium to trickle back into the cell stores, STIM1 was also inhibiting the function of the crucial and widespread voltage-operated calcium channel, known as the L-type channel.

"At the time, we thought only electrically excitable cells, like cardiac, neural and skeletal cells, had L-type (or long-lasting) calcium channels," he said. "So it was surprising that the STIM1 protein known to function mostly in non-excitable cells was having a pretty profound effect on the L-type calcium channels."

"This is particularly true in tissue like smooth muscle where it is sort of like a hybrid between an excitable and a non-excitable cell, because it has the voltage-operated calcium channel and the Orai calcium channel, as well as the very powerful STIM sensing system," he said.

Gill said that the researchers' finding gives a common mechanism for calcium signaling in both excitable and non-excitable cells, a link that was never before known.

"It's a very basic finding, but it's another whole area of control that people didn't know about before," he said. "They knew there were L-type calcium channels in many non-excitable cells, but they didn't seem to have any function. Now it seems very possible that the reason they didn't function is that the STIM1 protein was suppressing their function."

The study was funded by grants from the National Institutes of Health and Novartis Institutes for Biomedical Research.


Story Source:

The above story is based on materials provided by Temple University. Note: Materials may be edited for content and length.


Journal Reference:

  1. C. Y. Park, A. Shcheglovitov, R. Dolmetsch. The CRAC Channel Activator STIM1 Binds and Inhibits L-Type Voltage-Gated Calcium Channels. Science, 2010; 330 (6000): 101 DOI: 10.1126/science.1191027

Cite This Page:

Temple University. "Protein provides link between calcium signaling in excitable and non-excitable cells." ScienceDaily. ScienceDaily, 1 October 2010. <www.sciencedaily.com/releases/2010/10/101001144035.htm>.
Temple University. (2010, October 1). Protein provides link between calcium signaling in excitable and non-excitable cells. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/10/101001144035.htm
Temple University. "Protein provides link between calcium signaling in excitable and non-excitable cells." ScienceDaily. www.sciencedaily.com/releases/2010/10/101001144035.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins